肝癌患者血清miRNA-4516的表达及其临床意义和靶基因的预测

王福花; 王春艳; 郭向云; 李峰; 杨云锋; 郭素堂

doi:10.3969/j.issn.1671-038X.2021.02.02

肝癌患者血清miRNA-4516的表达及其临床意义和靶基因的预测

- 1 山西省肿瘤医院分子生物室(太原, 030013);
- 2 山西省人民医院消化科
基金项目:
国家自然科学基金面上项目(No:81972840)

山西省重点研发计划项目(No:201903D321129)

详细信息

通讯作者: 郭素堂,Email:58998417@qq.com

中图分类号: R735.7

收稿日期: 2020-11-23

Expression of serum miRNA-4516 and its clinical significance and predicted target genes in hepatocellular carcinoma

- 1 Department of Molecular Biology, Shanxi Cancer Hospital and Institute, Taiyuan, 030013, China;
- 2 Department of Gastroenterology, Shanxi Provincial People's Hospital

More Information

Corresponding author: GUO Sutang, E-mail: 58998417@qq.com

Received Date: 23 November 2020

摘要

摘要: 目的:探讨血清miRNA-4516在肝癌中的表达情况及其临床意义并预测其可能的靶基因。方法:收集100例肝癌患者和同期体检的100例健康人血清样本,采用RT-PCR测定血清miRNA-4516表达水平,分析其与肝癌临床病理的相关性,最后通过生物信息学预测miRNA-4516可能的靶基因。结果:经分析血清miRNA-4516相对表达水平,肝癌患者高于正常对照组(P=0.001);与肝癌的分化程度有关(P=0.015);而与患者年龄、性别、AFP表达量、是否肝炎肝硬化、是否转移无相关性(P>0.05)。通过生物信息学分析,miRNA-4516预测的靶基因多数与转录因子有关。结论:miRNA-4516有可能通过调节转录因子在肝癌发生、发展中起作用。
- 肝癌 /
- miRNA-4516 /
- 靶基因
Abstract: Objective: This study sought to detect the expression and clinical significance of serum miRNA-4516 in hepatocellular carcinoma, and to predict its target genes through bioinformation.Methods: A total of 100 patients with hepatocellular carcinoma and 100 healthy persons were selected. The level of serum miRNA-4516 was detected by RT-PCR. The correlation of serum miRNA-4516 expression levels with the clinical characteristics of hepatocellular carcinoma was analyzed. Bioinformatics methods were used to analyze target genes of miRNA-4516.Results: Serum miRNA-4516 was highly expressed in patients with hepatocellular carcinoma in contrast with controls(P=0.001). The high expression of miRNA-4516 was shown to be related to differential grade of hepatocellular carcinoma(P=0.015), Whereas the high expression of miRNA-4516 didn't correlate with age, sex, AFP, hepaitis, cirrhosis and distant metastasis of the patients(P>0.05). Target genes predictived by information are largely transcription factor.Conclusion: miRNA-4516 may play a role in the occurrence and development of hepatocellular carcinoma through transcription factor.
- hepatocellular carcinoma /
- serum miRNA-4516 /
- target genes

HTML全文

参考文献(17)

[1]	Kim NG,Nguyen PP,Dang H,et al.Temporal trends in disease presentation and survival of patients with hepatocellular carcinoma:A real-world experience from 1998 to 2015[J].Cancer,2018,124(12):2588-2598.
[2]	Lee D,Xu IM,Chiu DK,et al.Folate cycle enzyme MTHFD1 L confers metabolic advantages in hepatocellular carcinoma[J].J Clin Invest,2017,127(5):1856-1872.
[3]	Shenouda SK,Alahari SK.MicroRNA function in cancer:oncogene or a tumor suppressor?[J].Cancer Metastasis Rev,2009,28(3-4):369-378.
[4]	Shah R,Tanriverdi K,Levy D,et al.Discordant Expression of Circulating microRNA from Cellular and Extracellular Sources[J].PLoS One,2016,11(4):e0153691.
[5]	王福花,李峰,王春艳,等.血清miRNA表达谱在肝细胞癌中的差异性研究[J].中国中西医结合消化杂志,2020,28(6):423-426.
[6]	Chen W,Zheng R,Baade PD,et al.Cancer statistics in China,2015[J].CA Cancer J Clin,2016,66(2):115-132.
[7]	Abreu P,Ferreira R,Mineli V,et al.Alternative Biomarkers to Predict Tumor Biology in Hepatocellular Carcinoma[J].Anticancer Res,2020,40(12):6573-6784.
[8]	Nikpay M,Beehler K,Valsesia A,et al.Genome-wide identification of circulating-miRNA expression quantitative trait loci reveals the role of several miRNAs in the regulation of cardiometabolic phenotypes[J].Cardiovasc Res,2019,115(11):1629-1645.
[9]	Keller A,Fehlmann T,Backes C,et al.Competitive learning suggests circulating miRNA profiles for cancers decades prior to diagnosis[J].RNA Biol,2020,17(10):1416-1426.
[10]	Chen S,Xu M,Zhao J,et al.MicroRNA-4516 suppresses pancreatic cancer development via negatively regulating orthodenticle homeobox 1[J].Int J Biol Sci,2020,16(12):2159-2169.
[11]	Jin XH,Lu S,Wang AF.Expression and clinical significance of miR-4516 and miR-21-5p in serum of patients with colorectal cancer[J].BMC Cancer,2020,20(1):241.
[12]	Wang Z,Xu R.lncRNA PART1 Promotes Breast Cancer Cell Progression by Directly Targeting miR-4516[J].Cancer Manag Res,2020,12:7753-7760.
[13]	Shimojo M,Kasahara Y,Inoue M,et al.A gapmer antisense oligonucleotide targeting SRRM4 is a novel therapeutic medicine for lung cancer[J].Sci Rep,2019,9(1):7618.
[14]	Cui T,Bell EH,McElroy J,et al.miR-4516 predicts poor prognosis and functions as a novel oncogene via targeting PTPN14 in human glioblastoma[J].Oncogene,2019,38(16):2923-2936.
[15]	Li O,Li Z,Tang Q,et al.Long Stress Induced Non-Coding Transcripts 5(LSINCT5) Promotes Hepatocellular Carcinoma Progression Through Interaction with High-Mobility Group AT-hook 2 and MiR-4516[J].Med Sci Monit,2018,24:8510-8523.
[16]	Kim E,Kim D,Lee JS,et al.Capicua suppresses hepatocellular carcinoma progression by controlling the ETV4-MMP1 axis[J].Hepatology,2018,67(6):2287-2301.
[17]	Yang QX,Zhong S,He L,et al.PBK overexpression promotes metastasis of hepatocellular carcinoma via activating ETV4-uPAR signaling pathway[J].Cancer Lett,2019,452:90-102.